Skip to main content
. 2016 Nov 24;2016(11):CD004028. doi: 10.1002/14651858.CD004028.pub4

Lee 1996.

Methods Allocation: randomised ‐ divided into 3 groups randomly
Blindness: not mentioned, assume open‐label
Participants Diagnosis: people with chronic schizophrenia, residual type according to DSM‐III‐R and had predominant negative symptoms evaluated by PANSS
Interventions Haloperidol + carbamazepine or haloperidol + valproate or haloperidol only
Outcomes Mental states: BPRS, PANSS, CGI
Depression: HRDS
Adverse events: SAS
Notes